Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on: June 08,2024

Investigators build a better targeted drug therapy using the power of computation

by Brigham and Women's HospitalCancer cell during cell division. Credit: National Institutes of HealthAntibody drug conjugates (ADCs)—cancer drugs that are designed to target and destroy canc

Updated on:June 08,2024

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on: January 12,2024

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on:January 12,2024

Researchers develop liquid biopsy test for pediatric solid tumors

by Children's Hospital Los AngelesCopy number alteration detection in liquid biopsies of pediatric solid tumor patients. Summary of copy number alteration (CNA) detection and disease status a

Updated on: January 30,2024

Researchers develop liquid biopsy test for pediatric solid tumors

by Children's Hospital Los AngelesCopy number alteration detection in liquid biopsies of pediatric solid tumor patients. Summary of copy number alteration (CNA) detection and disease status a

Updated on:January 30,2024

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

Updated on: January 12,2024

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

Updated on:January 12,2024

Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

bySPIEA three-channel camera separates Cherenkov emissions into red, green, and blue channels, allowing the investigation of the impact of variations in melanin and blood levels on the signal. T

Updated on: January 02,2024

Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

bySPIEA three-channel camera separates Cherenkov emissions into red, green, and blue channels, allowing the investigation of the impact of variations in melanin and blood levels on the signal. T

Updated on:January 02,2024

Nature-inspired peptide shows anti-tumor activity

by Forschung & Bildung GmbHStructure and synthesis of kalata-type cyclotides. Pie-shaped flow chart demonstrates the solid phase peptide synthesis of kalata-type cyclotides by example of T20K. The

Updated on: January 07,2024

Nature-inspired peptide shows anti-tumor activity

by Forschung & Bildung GmbHStructure and synthesis of kalata-type cyclotides. Pie-shaped flow chart demonstrates the solid phase peptide synthesis of kalata-type cyclotides by example of T20K. The

Updated on:January 07,2024

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t

Updated on: April 01,2024

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t

Updated on:April 01,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024

Researchers develop dual anti-tumor vaccine

by The University of Hong KongFrom the left: Dr Fengwei ZHANG, Professor Billy CHOW, Professor Kelvin YEUNG, and Professor Will Wei QIAO. Credit: The University of Hong KongA research team at the

Updated on: March 20,2024

Researchers develop dual anti-tumor vaccine

by The University of Hong KongFrom the left: Dr Fengwei ZHANG, Professor Billy CHOW, Professor Kelvin YEUNG, and Professor Will Wei QIAO. Credit: The University of Hong KongA research team at the

Updated on:March 20,2024

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro

Updated on: April 01,2024

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro

Updated on:April 01,2024

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on: March 21,2024

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on:March 21,2024

Exercise can increase the number of immune cells in the bloodstream of cancer patients

by University of TurkuCredit: Unsplash/CC0 Public DomainExercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients' quality of life

Updated on: February 23,2024

Exercise can increase the number of immune cells in the bloodstream of cancer patients

by University of TurkuCredit: Unsplash/CC0 Public DomainExercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients' quality of life

Updated on:February 23,2024